On July 23, 2018, Dthera Sciences (OTCPK:DTHR) closed the transaction. The company issued 3,925,000 common shares at a price of $0.65 per share for gross proceeds of $2,550,000 in the transaction. The company received funding in its third and final tranche of the transaction from accredited investors.